Literature DB >> 28372873

Clostridium perfringens bacteraemia, an analysis of 28 cases over 10 years in a university hospital of Madrid.

M ª Fátima Lopez-Fabal1, Nuria Sanz2, Mario Ruiz-Bastian2, Carlos Barros3, Jose-Luis Gomez-Garces2.   

Abstract

Bacteraemia caused by anaerobic bacteria is rare in the hospital setting. The Clostridium genus is the second most common cause of these infections, particularly Clostridium perfringens, which has a high mortality rate. However, reviews in the literature of these infections are scarce. The aim of this study was to retrospectively document the incidence, clinical characteristics and risk factors involved in the acquisition of bacteraemia caused by C. perfringens among patients treated at our hospital over a 10-year period. Twenty-eight patients with C. perfringens bacteraemia were included in the study. We evaluated pre-existing comorbidities, the source of bacteraemia, clinical features, the antimicrobial treatment administered and patient outcome. C. perfringens bacteraemia occurs rarely in our setting, but with a very high mortality rate. This rate is associated with old age and pre-existing, largely gastrointestinal malignancies. It presents with few specific symptoms but requires rapid and appropriate diagnosis and treatment to reduce the high mortality of this infection.
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Entities:  

Keywords:  Bacteraemia; Bacteriemia; Clostridium perfringens; Epidemiology; Epidemiología

Mesh:

Year:  2017        PMID: 28372873     DOI: 10.1016/j.eimc.2017.02.002

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin (Engl Ed)        ISSN: 2529-993X


  1 in total

1.  Structural Changes in Trabecular Bone, Cortical Bone and Hyaline Cartilage as Well as Disturbances in Bone Metabolism and Mineralization in an Animal Model of Secondary Osteoporosis in Clostridium perfringens Infection.

Authors:  Agnieszka Tomczyk-Warunek; Tomasz Blicharski; Siemowit Muszyński; Ewa Tomaszewska; Piotr Dobrowolski; Rudolf Blicharski; Jaromir Jarecki; Anna Arczewska-Włosek; Sylwester Świątkiewicz; Damian Józefiak
Journal:  J Clin Med       Date:  2021-12-30       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.